Brian Klatt
Overview
Explore the profile of Brian Klatt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chelly J, Klatt B, OMalley M, Groff Y, Kearns J, Khetarpal S, et al.
J Pain Relief
. 2024 Feb;
12(Suppl 1).
PMID: 38343757
Introduction: Aromatherapy is claimed to be effective for the treatment of psychosocial disorders, but objective evidence of its effectiveness is still lacking. Psychosocial disorders have been demonstrated to increase postoperative...
2.
Goodman S, Springer B, Chen A, Davis M, Fernandez D, Figgie M, et al.
J Arthroplasty
. 2022 Jun;
37(9):1676-1683.
PMID: 35732511
Objective: To develop updated American College of Rheumatology/American Association of Hip and Knee Surgeons guidelines for the perioperative management of disease-modifying medications for patients with rheumatic diseases, specifically those with...
3.
Goodman S, Springer B, Chen A, Davis M, Fernandez D, Figgie M, et al.
Arthritis Rheumatol
. 2022 Jun;
74(9):1464-1473.
PMID: 35722708
Objective: To develop updated guidelines for the perioperative management of disease-modifying medications for patients with rheumatic diseases, specifically those with inflammatory arthritis (IA) and those with systemic lupus erythematosus (SLE),...
4.
Goodman S, Springer B, Chen A, Davis M, Fernandez D, Figgie M, et al.
Arthritis Care Res (Hoboken)
. 2022 Jun;
74(9):1399-1408.
PMID: 35718887
Objective: To develop updated guidelines for the perioperative management of disease-modifying medications for patients with rheumatic diseases, specifically those with inflammatory arthritis (IA) and those with systemic lupus erythematosus (SLE),...
5.
Shah N, Hersh B, Kreger A, Sayeed A, Bullock A, Rothenberger S, et al.
Clin Infect Dis
. 2020 Jun;
72(1):177-178.
PMID: 32518947
No abstract available.
6.
Vaudreuil N, Gulledge C, McGlaston T, Bove A, Klatt B
Physiother Theory Pract
. 2019 Dec;
37(12):1353-1359.
PMID: 31852404
: Post-operative day (POD) 0 physical therapy (PT) after total knee arthroplasty (TKA) has been associated with improved outcomes such as shorter hospital length of stay (LOS), though patient performance...
7.
Shah N, Hersh B, Kreger A, Sayeed A, Bullock A, Rothenberger S, et al.
Clin Infect Dis
. 2019 Jul;
70(6):1260-1261.
PMID: 31292620
No abstract available.
8.
Shah N, Hersh B, Kreger A, Sayeed A, Bullock A, Rothenberger S, et al.
Clin Infect Dis
. 2019 Apr;
70(4):559-565.
PMID: 30944931
Background: Total knee arthroplasty (TKA) periprosthetic joint infection (PJI) can be managed with debridement, antibiotic therapy, and implant retention (DAIR). Oral antibiotics can be used after DAIR for an extended...
9.
Alijanipour P, Karam J, Llinas A, Vince K, Zalavras C, Austin M, et al.
J Orthop Res
. 2014 Jan;
32 Suppl 1:S60-80.
PMID: 24464899
No abstract available.
10.
Alijanipour P, Karam J, Llinas A, Vince K, Zalavras C, Austin M, et al.
J Arthroplasty
. 2013 Dec;
29(2 Suppl):49-64.
PMID: 24342274
No abstract available.